Addus HomeCare (NASDAQ:ADUS) Rating Lowered to “Buy” at Wall Street Zen

Addus HomeCare (NASDAQ:ADUS) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday.

Other research analysts have also issued reports about the stock. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Barclays decreased their price target on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research note on Tuesday, February 24th. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Wednesday, February 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Finally, Stephens reduced their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $99.28 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.80 and a current ratio of 1.80. Addus HomeCare has a one year low of $88.96 and a one year high of $124.43. The firm has a market capitalization of $1.85 billion, a P/E ratio of 19.06, a PEG ratio of 1.39 and a beta of 0.92. The company’s fifty day moving average is $106.90 and its two-hundred day moving average is $111.61.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 4,988 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $533,616.24. Following the completion of the sale, the chief executive officer owned 185,514 shares in the company, valued at approximately $19,846,287.72. This trade represents a 2.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Darby Anderson sold 733 shares of the business’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $78,416.34. Following the completion of the transaction, the executive vice president directly owned 46,642 shares of the company’s stock, valued at $4,989,761.16. The trade was a 1.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 16,610 shares of company stock valued at $1,768,970. Company insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Hohimer Wealth Management LLC boosted its position in Addus HomeCare by 3.4% in the 3rd quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock valued at $320,000 after buying an additional 88 shares during the last quarter. Ameritas Investment Partners Inc. grew its stake in shares of Addus HomeCare by 5.0% during the second quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock valued at $214,000 after acquiring an additional 89 shares in the last quarter. Amalgamated Bank grew its stake in shares of Addus HomeCare by 1.8% during the third quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock valued at $618,000 after acquiring an additional 93 shares in the last quarter. Oregon Public Employees Retirement Fund increased its position in shares of Addus HomeCare by 2.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after acquiring an additional 103 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Addus HomeCare by 6.3% during the third quarter. GAMMA Investing LLC now owns 1,778 shares of the company’s stock worth $210,000 after acquiring an additional 105 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.